The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Qiagen NV (QGEN) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.64, or -1.64%, to $38.31. The Qiagen NV has recorded 16,802 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted QIAGEN launches complete Sample to Insight workflow for microbiome research.
The company is listed on the NYSE and operates within the Diagnostics & Research industry segment. At the end of the last regular session, the stock closed at $38.95 and fluctuated between $39.39 as its day high and $38.70 as its day low. The current market capitalization of Qiagen NV is $8.88B. A total of 1.06 million shares were traded on the day, compared to an average of 1.37M shares.
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, QGEN has seen 0 BUY and 2 SELL insider trades, representing the acquisition of 0 and the disposition of 1,341,772 shares. Over the last 12 months, there were 21 BUYs and 12 SELLs from insiders. Insiders purchased 14,314,574 shares during that period but sold 1,691,650.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for QGEN in the last 3 months, the mean price target is $48.31 with high estimates of $60.00 and low estimates of $42.00. In terms of 52-week highs and lows, QGEN has a high of $51.18 and a low of $34.74.
As of this writing, QGEN has an earnings estimate of $0.48 per share for the current quarter. EPS was calculated based on a consensus of 11 estimates, with a high estimate of $0.49 per share and a lower estimate of $0.47. The company reported an EPS of $0.51 in the last quarter, which was 8.50% higher than expectations of $0.47.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. QGEN’s latest balance sheet shows that the firm has $1.07B in Cash & Short Term Investments as of fiscal 2021. There were $1.94B in debt and $1.52B in liabilities at the time. Its Book Value Per Share was $16.19, while its Total Shareholder’s Equity was $3.10B.
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for QGEN is Buy with a score of 3.91.